Search
What are you looking for?
Start main content

Press Releases

Press Releases

https://www.med.cuhk.edu.hk/press-releases/cuhk-launches-hong-kongs-first-pilot-integrative-medicine-programme-in-multiple-sclerosis-for-managing-cognitive-symptoms-relieving-fatigue-and-disease-control
https://www.med.cuhk.edu.hk/press-releases/cuhk-launches-hong-kongs-first-pilot-integrative-medicine-programme-in-multiple-sclerosis-for-managing-cognitive-symptoms-relieving-fatigue-and-disease-control

CUHK Launches Hong Kong’s First Pilot Integrative Medicine Programme in Multiple Sclerosis for Managing Cognitive Symptoms, Relieving Fatigue, and Disease Control

The first integrative medicine pilot programme for multiple sclerosis patients in Hong Kong is about to be launched by The Chinese University of Hong Kong’s (CUHK) Hong Kong Institute of Integrative Medicine (HKIIM). Under the programme, patients will receive western medications, Chinese herbal therapy and acupuncture under the close supervision and care of the clinical team. The objective of the programme is disease control, at the same time  managing patients’ cognitive symptoms and fatigue and thereby restoring mobility.

 

MS Prevalence rate has risen by 40% in seven years

 

Multiple sclerosis (MS) is affecting an estimated 2.5 million young adults worldwide. According to the latest figures of the Hong Kong Multiple Sclerosis Registry of CUHK, the prevalence rate of MS is mounting, from 4.8 per 100,000 people in 2008 to 6.8 per 100,000 people in 2015. In Hong Kong, more than 500 people have been diagnosed with MS. The age of onset is between 20 and 30 years, and more than 70% are female.

 

MS is the most common central nervous system demyelinating disease. Its exact etiology remains unknown. The disease occurs when the insulating covers of nerve cells in the brain and spinal cord are damaged, affecting the functions of the optic nerve, brain, brainstem, cerebellum or spinal cord. Once the nerve fails to transmit signals properly, the respective functions will be disrupted. That results in a wide range of signs and symptoms, including blurred vision, muscle weakness, memory loss, and bladder difficulties.

 

Managing MS symptoms with Western and Chinese medications

 

Most patients develop a relapsing-remitting course in the beginning and if they fail to receive  timely treatment, the recurrent damage may eventually lead to disability. Interferon is commonly used as the first-line treatment in Hong Kong, nowadays. Researches suggest that early stage disease is most responsive to disease modifying treatments, which can significantly reduce the relapse rate (by 30%) and long term disability. However, newer agents such as oral medications and infusion biologics, can additionally prevent relapses (>50%), reduce MRI lesions and progression, and have a higher chance of achieving ‘disease-freedom’, or ‘no evidence of disease activity’ – which is considered a new benchmark of disease control. Nevertheless, fatigue (>80%) and cognitive symptoms (40-60%) are prevalent among MS patients and difficult to treat.. The physical impairment disables patients’ mobility, problem-solving skills and self-care ability, resulting in a poorer quality of life.

 

To address and solve that unmet need, HKIIM has been, since August 2014, exploring options offered by Integrative Medicine (IM) in treating these important symptoms of MS by close collaboration between neurologists and Chinese medicine practitioners (CMPs). Dr. Alexander Yuk Lun LAU, Assistant Professor, Department of Medicine and Therapeutics and Deputy Chief Clinician of Integrative Medical Centre, Faculty of Medicine said, ‘Per our discussion with CMPs, Chinese herbal medicine and acupuncture are found efficacious in resolving MS symptoms. We have thus started exploring how western clinicians and CMPs may collaborate on the diagnosis, assessment, monitoring and treatment of MS.’

 

Mr. William Hoi Ngai CHEUNG, Professional Consultant, HKIIM and Deputy Chief CMP of the Integrative Medical Centre, Faculty of Medicine, explained, ‘MS is a disorder of the brain and spinal cord. Traditional Chinese Medicine views the kidneys as the center of the body's “yin” and “yang”. Kidneys store yin-essence in order to produce marrow to enrich the brain, therefore in the Chinese medicine perspective, MS is associated with a “kidney deficiency”. Patients often demonstrate symptoms of lower limbs weakness, dizziness and insomnia at an early stage. When the disease evolves into a chronic progressive phase, patients may suffer from listlessness, fatigue and heavy limbs, or even cold limbs and waist. Paraplegia may result in some severe cases. On the basis of the syndrome differentiation of the MS patients, CMPs may then prescribe suitable Chinese herbal formulae. Acupuncture is an effective treatment modality in mind-refreshing, dredging meridian, relieving numbness and improving coordination. Acupuncture can be used concomitantly to invigorate “qi”, so as to manage the symptoms of listless, muscle weakness and incontinence of some patients.’

 

Dr. Vincent Chi Ho CHUNG, Assistant Professor, School of Public Health and Primary Care and Associate Director (Education) of HKIIM stated that international studies also showed Chinese herbal medicine and acupuncture are efficacious therapies for the management of MS. A study found the disability score and the relapse rate in patients with MS improved after receiving Chinese herbal medicine. Another study also showed that acupuncture benefitted MS patients in reducing fatigue, pain and mood disturbances. There was also an improvement found in patients’ quality of life after treatment. Both studies concluded that no significant side effects were observed in patients who underwent Chinese herbal treatment and acupuncture.

 

Dr. Alexander Yuk Lun LAU continued, ‘There were 20 MS patients who had received IM care conjointly managed by neurologists, CMPs and nurses in our clinic. Initial findings showed an improvement in fatigue, numbness and cognitive functions. Our IM clinical team is going to launch a pilot programme for a hundred patients with confirmed relapsing multiple sclerosis. Selected patients will receive an 8-week IM treatment of herbs and/or acupuncture. This programme aims to evaluate the treatment outcome of the IM model in managing fatigue and cognitive symptoms associated with multiple sclerosis.’ Neurologists, CMPs and nurses will collaborate to assess and monitor patients’ health conditions. Clinical toxicologists will also be involved and render advice on herb-drug interactions. Dr. LAU remarked, ‘MS is most often diagnosed in young adults. If the IM approach is found to be efficacious in ameliorating the disturbing symptoms of fatigue and cognitive impairment, it might open up a novel therapeutic modality for MS. As such, patients would have chances to regain their strengths in recreation, daily routines and self-care.’

 

Prof. Justin Che Yuen WU, Associate Dean (Development), Faculty of Medicine and Director of HKIIM concluded, ‘Our integrative medicine models have three distinctive features. First, we have a designated team of western clinicians and CMPs who are responsible for the design and implementation of programmes. Second, the clinical team develops close and effective communications in the clinical setting. Third, the clinical team is dedicated to developing quality pragmatic clinical trials (original research), with an aim to evaluate the integrative medicine patient care model and treatment outcomes. We are dedicated to establishing a platform which respects and maximizes the individual strength of Western and Chinese medicine to precipitate the development of integrative medicine. If we achieve breakthrough results showing that integrative treatment could be a safe and more effective treatment modality in certain diseases, different areas of medical practice could be bridged and benefit the community as a whole.’

 

Established with funding from The Hong Kong Jockey Club Charities Trust, CUHK’s Hong Kong Institute of Integrative Medicine is the first of its kind in the city, incorporating Chinese and Western integrative medical treatment, education and research under one roof.

 

The Hong Kong Jockey Club Charities Trust has been a long-standing supporter of various projects that promotes the development of Chinese medicine in Hong Kong, and helps meet the needs of different patients and facilitate professional training. They include the establishment of traditional Chinese Medicine out-patient clinic and dispensary; and the set-up of a Chinese Herbs Garden. This integrative medicine pilot programme for multiple sclerosis patients is also supported by the Hong Kong Jockey Club Charities Trust. For participation or enquiry, please dial 2873-3100 or send email to hkiim@cuhk.edu.hk .

 

Prof. Justin WU (3rd left)

Prof. Justin WU (3rd left), Director of CUHK’s Hong Kong Institute of Integrative Medicine (HKIIM); Dr. Vincent CHUNG (1st left), Associate Director (Education) of HKIIM; Mr. William CHEUNG (4th right), Professional Consultant of HKIIM; Prof. Songming LIANG (3rd right), Honorary Visiting Professor of HKIIM; and Dr. Alexander LAU (4th from left), Deputy Chief Clinician of CUHK’s Integrative Medical Centre; introduce the pilot integrative medicine programme for multiple sclerosis patients to be launched by HKIIM.

Multiple sclerosis patients Gary (2nd left)

Multiple sclerosis patients Gary (2nd left) and Don (2nd right) have been suffering from associated symptoms since 2013 and 2014, respectively. Their symptoms are relieved after receiving Integrative Medicine treatment.

Dr. Alexander LAU states that

Dr. Alexander LAU states that the prevalence rate of multiple sclerosis in Hong Kong has been increased by more than 40% from 2008 to 2015.

More Press Releases

CUHK Launches First Chinese Medicine MOOC Course in English on Coursera Bringing Chinese Medicine Global and Household

CUHK Launches First Chinese Medicine MOOC Course in English on Coursera Bringing Chinese Medicine Global and Household

Education
CUHK World’s First Study Confirms A New Colorectal Cancer High Risk Group

CUHK World’s First Study Confirms A New Colorectal Cancer High Risk Group

Research
CUHK Research by Medical Undergraduates Reveals Poor Medication Adherence Among Hypertensive Patients in Hong Kong

CUHK Research by Medical Undergraduates Reveals Poor Medication Adherence Among Hypertensive Patients in Hong Kong

Research
CU Medicine and International Surgeons Suggest Patients with Positive COVID-19 Results Should Delay Surgery for Seven Weeks to Reduce Death Risk

CU Medicine and International Surgeons Suggest Patients with Positive COVID-19 Results Should Delay Surgery for Seven Weeks to Reduce Death Risk

International collaboration
CUHK and International Experts in Diabetes Care Joined Hands for Four Years Developing a Multicomponent, Integrated Strategy for Diabetes under The Lancet

CUHK and International Experts in Diabetes Care Joined Hands for Four Years Developing a Multicomponent, Integrated Strategy for Diabetes under The Lancet

International collaboration
CU Medicine Studies Highlight Smoking as a Contributing Factor for Bladder Cancer and  Develop an International Collaborative Consensus on En Bloc Resection to Treat the Disease

CU Medicine Studies Highlight Smoking as a Contributing Factor for Bladder Cancer and Develop an International Collaborative Consensus on En Bloc Resection to Treat the Disease

Research
CUHK Successfully Performed World’s First Colorectal Endoscopic Submucosal Dissection  Using Flexible Endoscopic Robotic System

CUHK Successfully Performed World’s First Colorectal Endoscopic Submucosal Dissection Using Flexible Endoscopic Robotic System

Surgical advancement
CUHK Pioneers Whole Genome Sequencing for Identifying the Chromosomal Abnormalities in Couples with Recurrent Miscarriages

CUHK Pioneers Whole Genome Sequencing for Identifying the Chromosomal Abnormalities in Couples with Recurrent Miscarriages

Research
CU Medicine Announces the Community Response Study Results During the Early Phase of the COVID-19 Outbreak in Hong Kong

CU Medicine Announces the Community Response Study Results During the Early Phase of the COVID-19 Outbreak in Hong Kong

Research
The Helmsley Charitable Trust Funds Asian Research into Babies’ Gut Microbiota and Crohn’s Disease

The Helmsley Charitable Trust Funds Asian Research into Babies’ Gut Microbiota and Crohn’s Disease

Research
CUHK Study Sees the Exposure to Farm Environment  Is Beneficial for Children to Prevent Asthma

CUHK Study Sees the Exposure to Farm Environment Is Beneficial for Children to Prevent Asthma

Research
Chinese Women with Polycystic Ovarian Syndrome have 4-fold Higher Risk of Developing Diabetes

Chinese Women with Polycystic Ovarian Syndrome have 4-fold Higher Risk of Developing Diabetes

Research
Multicomponent Frailty Prevention Programme Reduces Frailty Over 80% of Pre-frail Elderly Reverse to Robust Phenotype

Multicomponent Frailty Prevention Programme Reduces Frailty Over 80% of Pre-frail Elderly Reverse to Robust Phenotype

Research
CUHK Validates the Enhanced UK Fetal Medicine Foundation’s Triple Test Can Double the Detection Rate of Preterm Preeclampsia in Asian Pregnant Women

CUHK Validates the Enhanced UK Fetal Medicine Foundation’s Triple Test Can Double the Detection Rate of Preterm Preeclampsia in Asian Pregnant Women

Research
CUHK Pioneers Whole Genome Sequencing for Prenatal Diagnosis in Hong Kong

CUHK Pioneers Whole Genome Sequencing for Prenatal Diagnosis in Hong Kong

Research
CUHK Study Proves Low-Dose Tricyclic Antidepressant (TCA) Effective in Treating Patients with Refractory Functional Dyspepsia

CUHK Study Proves Low-Dose Tricyclic Antidepressant (TCA) Effective in Treating Patients with Refractory Functional Dyspepsia

Research
CUHK Leads a Multinational Study that Finds New Treatment Paradigm of Mutated Lung Cancer

CUHK Leads a Multinational Study that Finds New Treatment Paradigm of Mutated Lung Cancer

Research
CUHK-led Study Reveals Novel Mechanism for the Development of Atherosclerosis Setting New Treatment Directions to Cardiovascular Diseases

CUHK-led Study Reveals Novel Mechanism for the Development of Atherosclerosis Setting New Treatment Directions to Cardiovascular Diseases

Research
CUHK Launches World’s First Study on Ovum Ageing and Female Infertility by Using Single-Cell Genomics Technology

CUHK Launches World’s First Study on Ovum Ageing and Female Infertility by Using Single-Cell Genomics Technology

Research
CUHK World’s First Study Sets a New Direction on Aspirin Use after Lower Gastrointestinal Hemorrhage

CUHK World’s First Study Sets a New Direction on Aspirin Use after Lower Gastrointestinal Hemorrhage

Research
CUHK Discovers Fatty Liver Causing Severe Liver Fibrosis or Cirrhosis in 1 Out of 5 Diabetic Patients

CUHK Discovers Fatty Liver Causing Severe Liver Fibrosis or Cirrhosis in 1 Out of 5 Diabetic Patients

Research
CUHK Opens Therese Pei Fong Chow Research Centre for Prevention of Dementia and Establishes a One-stop Online Platform to Provide Information on Dementia

CUHK Opens Therese Pei Fong Chow Research Centre for Prevention of Dementia and Establishes a One-stop Online Platform to Provide Information on Dementia

Research
CUHK Asia’s First Comprehensive Epidemiological Study on Health Impact of Household Cleaning Products on Children Reveals Frequent Use of Household Cleaning Products Increase Risk of Triggering Rhinitis in Children

CUHK Asia’s First Comprehensive Epidemiological Study on Health Impact of Household Cleaning Products on Children Reveals Frequent Use of Household Cleaning Products Increase Risk of Triggering Rhinitis in Children

Research
CUHK Sets up the Global First Research Registry on Early Onset Dementia in Chinese Population

CUHK Sets up the Global First Research Registry on Early Onset Dementia in Chinese Population

Research
CUHK and HKU Researchers Introduce 3D Printing Technology in Complex Cardiac Surgery Procedures

CUHK and HKU Researchers Introduce 3D Printing Technology in Complex Cardiac Surgery Procedures

Research
CUHK Jointly Discovers New Therapeutic Solution for Minor Stroke in Global Study with over 30 Countries

CUHK Jointly Discovers New Therapeutic Solution for Minor Stroke in Global Study with over 30 Countries

Research
CUHK Sees Early Evaluation of TIA Patients Reduce Rate of Stroke by 70% in a Global Study of 21 Countries

CUHK Sees Early Evaluation of TIA Patients Reduce Rate of Stroke by 70% in a Global Study of 21 Countries

Research
CUHK Research Shows 1 in 5 Throat Cancer Patients in HK is HPV infected

CUHK Research Shows 1 in 5 Throat Cancer Patients in HK is HPV infected

Research
CUHK Conducts Hong Kong’s First Study on Seven Common Respiratory Viruses Revealing Respiratory Syncytial Virus and Influenza A as Prevalent Fatal Types

CUHK Conducts Hong Kong’s First Study on Seven Common Respiratory Viruses Revealing Respiratory Syncytial Virus and Influenza A as Prevalent Fatal Types

Research
CUHK/International Study Implicates a Gene in Alzheimer’s disease

CUHK/International Study Implicates a Gene in Alzheimer’s disease

Research
Asia’s First Research by CUHK on Patients’ Lifestyle Reveals Personalised Modification Programme Effective in Reducing Severity of OSA

Asia’s First Research by CUHK on Patients’ Lifestyle Reveals Personalised Modification Programme Effective in Reducing Severity of OSA

Research
CUHK Latest Research Reveals FMT Effectiveness Triples that of Conventional Treatment

CUHK Latest Research Reveals FMT Effectiveness Triples that of Conventional Treatment

Research
CUHK Introduces New Material for Osteoporosis-related Bone Fracture Effectively Reduces Healing Time and Enhances Bone Strength Both by 30%

CUHK Introduces New Material for Osteoporosis-related Bone Fracture Effectively Reduces Healing Time and Enhances Bone Strength Both by 30%

Research
CUHK Highlights the Significance of Hospital Infection Control System in Controlling MERS

CUHK Highlights the Significance of Hospital Infection Control System in Controlling MERS

Research
CUHK Estimates Local Smokers Spend over HKD1 Million on Tobacco in Life

CUHK Estimates Local Smokers Spend over HKD1 Million on Tobacco in Life

Research
CUHK Advocates Stringent Control of Cardiovascular Risks for Reopening of Narrowed Brain Arteries - A New Paradigm to Prevent Recurrent Stroke (Available in Chinese only)

CUHK Advocates Stringent Control of Cardiovascular Risks for Reopening of Narrowed Brain Arteries - A New Paradigm to Prevent Recurrent Stroke (Available in Chinese only)

Research
CUHK Latest Research Reveals over 100,000 New Non-alcoholic Fatty Liver Cases in Hong Kong Annually

CUHK Latest Research Reveals over 100,000 New Non-alcoholic Fatty Liver Cases in Hong Kong Annually

Research
CUHK Reveals Hepatitis B Prevalence Among Pregnant Women Remains High Despite More Than 25 Years of Universal Hepatitis B Vaccination

CUHK Reveals Hepatitis B Prevalence Among Pregnant Women Remains High Despite More Than 25 Years of Universal Hepatitis B Vaccination

Research
Vice Minister of National Health and Family Planning Commission Joined CUHK as Honorary Professor To Further Promote Development of Integrative Medicine

Vice Minister of National Health and Family Planning Commission Joined CUHK as Honorary Professor To Further Promote Development of Integrative Medicine

Milestone
CUHK Study Reveals Peer Support Can Reduce Hospital Admission of Distressed Diabetes Patients

CUHK Study Reveals Peer Support Can Reduce Hospital Admission of Distressed Diabetes Patients

Research
Joint Study by CUHK and HKSH Reveals Patients with Comorbid REM Sleep Behavior Disorder and Depression may Suffer from Early-stage Neurodegeneration

Joint Study by CUHK and HKSH Reveals Patients with Comorbid REM Sleep Behavior Disorder and Depression may Suffer from Early-stage Neurodegeneration

Research
CUHK Succeeds in Treating Gastroesophageal Reflux Disease by Implantable Pulse Generator

CUHK Succeeds in Treating Gastroesophageal Reflux Disease by Implantable Pulse Generator

Surgical advancement
Screening Reveals Over 50% Community-dwelling Population Aged 65 or above are Pre-frail

Screening Reveals Over 50% Community-dwelling Population Aged 65 or above are Pre-frail

Research
CUHK Succeeded in Animal Study and Clinical Case of Percutaneous Nanoknife New Breakthrough in Cancer Treatment

CUHK Succeeded in Animal Study and Clinical Case of Percutaneous Nanoknife New Breakthrough in Cancer Treatment

Research
CUHK Opens Phase I Clinical Trial Centre To Step Up New Drug Development in Hong Kong

CUHK Opens Phase I Clinical Trial Centre To Step Up New Drug Development in Hong Kong

Research
CUHK Survey Reveals Relationship between Exercise Pattern and Emotional Health among Hong Kong People Mind-body Exercise Helps Reduce Risk of Mood Disorders

CUHK Survey Reveals Relationship between Exercise Pattern and Emotional Health among Hong Kong People Mind-body Exercise Helps Reduce Risk of Mood Disorders

Research
CUHK Establishes State Key Laboratory of Digestive Disease to Improve Diagnosis and Treatment of Digestive Diseases

CUHK Establishes State Key Laboratory of Digestive Disease to Improve Diagnosis and Treatment of Digestive Diseases

Research
CUHK Releases Research Results on Employment Status of Hong Kong Chronic Kidney Disease (CKD) Dialysis Patients and Promotes Predialysis Education Programme for Mid to Late Stage CKD patients

CUHK Releases Research Results on Employment Status of Hong Kong Chronic Kidney Disease (CKD) Dialysis Patients and Promotes Predialysis Education Programme for Mid to Late Stage CKD patients

Research
CUHK Conducts Asia's Largest Clinical Study on Life-threatening Infections caused by RSV and Influenza in Hong Kong Adults and Elderly

CUHK Conducts Asia's Largest Clinical Study on Life-threatening Infections caused by RSV and Influenza in Hong Kong Adults and Elderly

Research
CUHK Announces Latest Medical Treatment for Minor Stroke

CUHK Announces Latest Medical Treatment for Minor Stroke

Research
Hong Kong and Macau Among Top Three Regions in Asia-Pacific with the Highest Incidence of Inflammatory Bowel Disease CUHK Establishes Registry to Increase Public Awareness

Hong Kong and Macau Among Top Three Regions in Asia-Pacific with the Highest Incidence of Inflammatory Bowel Disease CUHK Establishes Registry to Increase Public Awareness

Research
CUHK Assessed and Treated Over 300 Young Ketamine Abusers with Urinary Tract Dysfunction Latest Research Reveals Effectiveness of Integrated Anti-inflammatory Therapy

CUHK Assessed and Treated Over 300 Young Ketamine Abusers with Urinary Tract Dysfunction Latest Research Reveals Effectiveness of Integrated Anti-inflammatory Therapy

Research
CUHK Research Reveals that Physical and Cognitive Activities can Maintain and Improve Brain Functions of Patients with Mild Cognitive Impairments

CUHK Research Reveals that Physical and Cognitive Activities can Maintain and Improve Brain Functions of Patients with Mild Cognitive Impairments

Research
CUHK Launches Territory-wide Screening Study for Early Detection of Nasopharynx Cancer Now Recruiting 20,000 Citizens to Join

CUHK Launches Territory-wide Screening Study for Early Detection of Nasopharynx Cancer Now Recruiting 20,000 Citizens to Join

Research
CUHK Research Reveals Impact of Mild Hearing Loss on School Children Now Recruiting Hearing Impaired Students for Research on Efficacy of Intervention

CUHK Research Reveals Impact of Mild Hearing Loss on School Children Now Recruiting Hearing Impaired Students for Research on Efficacy of Intervention

Research
CUHK discovers that 40% of Individuals at Risk of Coronary Heart Disease have Pre-cancerous Bowel Tumors

CUHK discovers that 40% of Individuals at Risk of Coronary Heart Disease have Pre-cancerous Bowel Tumors

Research

Our Expert List

Many experts under the Faculty of Medicine are available for media interview.
Please click here for the expert list or contact us.